Strategic Growth Digirad has a history of acquisitions and strategic realignment under a HoldCo structure, including ATRM Holdings and Ultrascan. This suggests potential sales opportunities in integrated imaging portfolios, cross-sell of Cardius and Ergo systems to newly consolidated entities, and bundled service agreements as the company expands its asset base.

Product Innovation With multiple generations of Cardius solid-state detectors and the Ergo general-purpose nuclear camera, Digirad demonstrates ongoing product development. Potential upsell or replacement deals could target clinics and imaging centers seeking the latest Cardius X series or Ergo systems with Attenuation Correction capabilities to modernize modalities.

Market Positioning As part of Catalyst MedTech's Equipment Solution division, Digirad occupies a niche in nuclear medicine imaging systems. This indicates opportunities to partner on turnkey imaging solutions, including integration with existing hospital IT, service contracts, and training packages to differentiate from competitors like Ziehm Imaging.

Geographic/Asset Growth Digirad has invested in manufacturing assets in Maine and has a larger revenue range implying scale and potentially national coverage. sales opportunities could focus on refurbished or refurbished-to-new transitions, asset disposition services, and extended warranties for a broader installed base.

Digital Engagement The tech stack highlights use of modern marketing and automation platforms (Pardot, HubSpot, Salesforce Marketing Cloud) and digital tracking. This enables targeted account-based sales outreach, personalized campaigns for imaging centers and hospitals, and data-driven follow-ups to convert prospects in the nuclear medicine segment.